Reproduction and juvenile animal toxicology studies in the rat with a new allergy vaccine adjuvanted with monophosphoryl lipid A (MPL®) for the treatment of grass pollen allergy
Authors:
- Simon HewingsSHSimon Hewings
- Murray SkinnerMSMurray Skinner
- 1 November 2011
- journal article
- Published by Elsevier in Reproductive Toxicology
- Vol. 32 (3) , 322-328
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Evaluation of the intramuscular administration of Cervarix™ vaccine on fertility, pre- and post-natal development in ratsReproductive Toxicology, 2011
- Allergen-specific immunotherapyImmunology Letters, 2009
- Update on mechanisms of allergen injection immunotherapyClinical & Experimental Allergy, 2008
- Pollinex® Quattro Ragweed: safety evaluation of a new allergy vaccine adjuvanted with monophosphoryl lipid A (MPL®) for the treatment of ragweed pollen allergyJournal of Applied Toxicology, 2007
- Safety evaluation of a new allergy vaccine containing the adjuvant monophosphoryl lipid A (MPL®) for the treatment of grass pollen allergyJournal of Applied Toxicology, 2004
- Allergen immunotherapy: current and new therapeutic strategiesExpert Opinion on Investigational Drugs, 2000
- Minimising the Risks of Allergen-Specific Injection ImmunotherapyDrug Safety, 2000
- L-Tyrosine as an Immunological AdjuvantInternational Archives of Allergy and Immunology, 1982
- Chemical Modification of Crude Timothy Grass Pollen ExtractInternational Archives of Allergy and Immunology, 1977
- Chemical Modification of Crude Timothy Grass Pollen ExtractInternational Archives of Allergy and Immunology, 1976